Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claes Wahlestedt

Showing results (161-170 of 204) with videos related to

Pageof 21
Sort By:
Aging Cell|June 7, 2019
Longevity-related molecular pathways are subject to midlife "switch" in humansJames A Timmons, Claude-Henry Volmar, Hannah Crossland, et al.
Advanced Genetics (Hoboken, N.J.)|June 8, 2023
Transcriptomics for Clinical and Experimental Biology Research: Hang on a SeqTanner Stokes, Haoning Howard Cen, Philipp Kapranov, et al.
Epigenetics|February 6, 2014
BET bromodomain proteins are required for glioblastoma cell proliferationChiara Pastori, Mark Daniel, Clara Penas, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2002
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat modelLars M Bjorklund, Rosario Sánchez-Pernaute, Sangmi Chung, et al.
Plos Genetics|May 10, 2006
Pseudo-messenger RNA: phantoms of the transcriptomeMartin C Frith, Laurens G Wilming, Alistair Forrest, et al.
Experimental Neurology|January 10, 2016
C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cellsRustam Esanov, Kinsley C Belle, Marka van Blitterswijk, et al.
Neurobiology of Disease|August 13, 2018
EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophreniaAndrea L Johnstone, Jiaqi J O'Reilly, Annika J Patel, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2022
Erratum to: JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse ModelJessica L Dennison, Claude-Henry Volmar, Farzaneh Modarresi, et al.
Molecular Cancer Research : MCR|October 20, 2020
Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal MelanomaJeffim N Kuznetsoff, Dawn A Owens, Andy Lopez, et al.
Journal of Alzheimer'S Disease : JAD|January 17, 2022
JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse ModelJessica L Dennison, Claude-Henry Volmar, Farzaneh Modarresi, et al.
Pageof 21

Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Aging Cell|June 7, 2019
Longevity-related molecular pathways are subject to midlife "switch" in humansJames A Timmons, Claude-Henry Volmar, Hannah Crossland, et al.
Advanced Genetics (Hoboken, N.J.)|June 8, 2023
Transcriptomics for Clinical and Experimental Biology Research: Hang on a SeqTanner Stokes, Haoning Howard Cen, Philipp Kapranov, et al.
Epigenetics|February 6, 2014
BET bromodomain proteins are required for glioblastoma cell proliferationChiara Pastori, Mark Daniel, Clara Penas, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2002
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat modelLars M Bjorklund, Rosario Sánchez-Pernaute, Sangmi Chung, et al.
Plos Genetics|May 10, 2006
Pseudo-messenger RNA: phantoms of the transcriptomeMartin C Frith, Laurens G Wilming, Alistair Forrest, et al.
Experimental Neurology|January 10, 2016
C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cellsRustam Esanov, Kinsley C Belle, Marka van Blitterswijk, et al.
Neurobiology of Disease|August 13, 2018
EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophreniaAndrea L Johnstone, Jiaqi J O'Reilly, Annika J Patel, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2022
Erratum to: JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse ModelJessica L Dennison, Claude-Henry Volmar, Farzaneh Modarresi, et al.
Molecular Cancer Research : MCR|October 20, 2020
Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal MelanomaJeffim N Kuznetsoff, Dawn A Owens, Andy Lopez, et al.
Journal of Alzheimer'S Disease : JAD|January 17, 2022
JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse ModelJessica L Dennison, Claude-Henry Volmar, Farzaneh Modarresi, et al.
Pageof 21